Get the Stockscreener App
2.89
0.70%
0.03
Xbiotech Inc stock is traded at $2.89, with a volume of 27,278.
It is up +0.70% in the last 24 hours and down -5.26% over the past month.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.
See More
Previous Close:
$2.86
Open:
$2.83
24h Volume:
27,278
Relative Volume:
0.55
Market Cap:
$88.12M
Revenue:
$4.01M
Net Income/Loss:
$-38.53M
P/E Ratio:
-2.2937
EPS:
-1.26
Net Cash Flow:
$-32.27M
1W Performance:
+1.41%
1M Performance:
-5.26%
6M Performance:
-62.16%
1Y Performance:
-61.55%
1-Day Range:
$2.775
$2.89
1-Week Range:
$2.775
$2.98
52-Week Range:
$2.65
$8.32
Xbiotech Inc Stock (XBIT) Company Profile
Name
Xbiotech Inc
Sector
Industry
Phone
512-386-2900
Address
5217 WINNEBAGO LANE, AUSTIN, TX
Compare XBIT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XBIT
Xbiotech Inc
|
2.89 | 86.59M | 4.01M | -38.53M | -32.27M | -1.26 |
|
ONC
Beone Medicines Ltd Adr
|
245.81 | 25.81B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
443.82 | 111.46B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 40.37M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
81.43 | 6.19B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
493.31 | 64.44B | 14.09B | 4.50B | 2.96B | 39.28 |
Xbiotech Inc Stock (XBIT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-14-19 | Initiated | Piper Jaffray | Overweight |
| Apr-21-17 | Downgrade | Noble Financial | Buy → Hold |
| Jun-28-16 | Reiterated | Noble Financial | Buy |
Xbiotech Inc Stock (XBIT) Latest News
Northern Trust Corp Buys 27,909 Shares of XBiotech Inc. (NASDAQ:XBIT) - Defense World
XBiotech (NASDAQ:XBIT) Stock Crosses Below 50-Day Moving AverageWhat's Next? - MarketBeat
XBiotech (NASDAQ:XBIT) Shares Cross Below 50 Day Moving AverageWhat's Next? - MarketBeat
Here's Why We're Not Too Worried About XBiotech's (NASDAQ:XBIT) Cash Burn Situation - Yahoo Finance
Barclays PLC Grows Position in XBiotech Inc. (NASDAQ:XBIT) - Defense World
XBiotech: Q1 Earnings Snapshot - New Haven Register
XBiotech stock hits 52-week low at $3.5 amid market challenges - MSN
Greenwich LifeSciences, Inc. (NASDAQ:GLSI) Shares Acquired by JPMorgan Chase & Co. - Defense World
JPMorgan Chase & Co. Acquires 5,930 Shares of XBiotech Inc. (NASDAQ:XBIT) - Defense World
JPMorgan Chase & Co. Buys 2,250 Shares of Permian Basin Royalty Trust (NYSE:PBT) - Defense World
JPMorgan Chase & Co. Trims Stake in Clipper Realty Inc. (NYSE:CLPR) - Defense World
XBiotech (NASDAQ:XBIT) Stock Price Passes Below 50-Day Moving AverageShould You Sell? - MarketBeat
Investor Network: XBiotech, Inc. to Host Earnings Call - ACCESS Newswire
Press Release Distribution & PR Platform - ACCESS Newswire
XBiotech (NASDAQ:XBIT) Stock Passes Below Fifty Day Moving AverageWhat's Next? - MarketBeat
Top Premarket Gainers - marketscreener.com
XBiotech (NASDAQ:XBIT) Shares Pass Above Fifty Day Moving AverageHere's Why - MarketBeat
XBiotech Inc. (NASDAQ:XBIT) Shares Sold by American Century Companies Inc. - Defense World
XBiotech stock plunges to 52-week low at $2.91 amid market challenges - Investing.com Canada
XBiotech Inc. (NASDAQ:XBIT) Short Interest Down 23.1% in March - MarketBeat
XBiotech Announces Board Member Retirement - TipRanks
XBiotech (NASDAQ:XBIT) Shares Pass Above 50-Day Moving AverageWhat's Next? - MarketBeat
Bank of New York Mellon Corp Has $360,000 Holdings in XBiotech Inc. (NASDAQ:XBIT) - Defense World
INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of XBiotech Inc. -- XBIT - ACCESS Newswire
XBiotech (NASDAQ:XBIT) Issues Quarterly Earnings Results - MarketBeat
XBiotech Inc. (XBIT) reports earnings - Quartz
Stocks Recover Some of This Week’s Losses as US Shutdown Seems Averted - TradingView
Stocks Rally as US Government Shutdown Risks Recede - TradingView
Xbiotech Inc Stock (XBIT) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.38%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):